Apeloa Pharmaceutical Co (000739.SZ) Stock Price
Apeloa Pharmaceutical Co Price
Revenue has compounded at 11.7% per year over the past 19 years to 9.76 B CNY. Earnings per share have grown at 11.8% per year over the last 19 years. Apeloa Pharmaceutical Co's net margin stands at 9.1%, down from 10.7% several years earlier. Apeloa Pharmaceutical Co currently offers a dividend yield of about 2.87%. The payout ratio is around 91% of earnings. The dividend has grown at 23.5% per year over the past 19 years. Analysts set a median price target of 18.87 CNY, implying 23.1% below the current price. Of 8 analysts, 7 rate the stock a buy — an overall Buy consensus.
Apeloa Pharmaceutical Co stock price
Apeloa Pharmaceutical Co business model & stock analysis
Frequently asked questions about Apeloa Pharmaceutical Co
Analysts currently set an average price target of 18.87 CNY for the Apeloa Pharmaceutical Co stock (median: 18.87 CNY), implying -23.1 % versus the latest price. The consensus is based on 8 analyst ratings.
8 analysts currently rate the Apeloa Pharmaceutical Co stock: 7 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Apeloa Pharmaceutical Co to generate revenue of 10.29 B CNY and earnings per share of 0.94 CNY.
Converted at the current exchange rate, the Apeloa Pharmaceutical Co share trades at 3.27 EUR (24.53 CNY).
The Apeloa Pharmaceutical Co share (000739.SZ) is listed on 1 stock exchanges, including: Shenzhen (000739.SZ).
The expected revenue of Apeloa Pharmaceutical Co is 10.29 B CNY. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Apeloa Pharmaceutical Co is 1.08 B CNY. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Apeloa Pharmaceutical Co is currently 26.04. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Apeloa Pharmaceutical Co stock.
The price-to-sales ratio (P/S) of Apeloa Pharmaceutical Co is currently 2.73. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Apeloa Pharmaceutical Co stock.
The Eulerpool Quality Score for Apeloa Pharmaceutical Co is 6/10.
The ISIN of Apeloa Pharmaceutical Co is CNE000000Q45. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Apeloa Pharmaceutical Co is 000739.SZ. The ticker symbol is used to trade Apeloa Pharmaceutical Co shares on the stock exchange.
Apeloa Pharmaceutical Co stock
Apeloa Pharmaceutical Co Peer Group
Apeloa Pharmaceutical Co Ticker
Apeloa Pharmaceutical Co FIGI
All fundamentals and in-depth analysis of Apeloa Pharmaceutical Co
Our stock analysis for Apeloa Pharmaceutical Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Apeloa Pharmaceutical Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.